Floatz logo

Anti-Mage-A3 Human Leukocyte Antigen Serotype Within Hla-A A Serotype Group -Restricted T-Cell Receptor

Melanoma

National Cancer Institute (NCI)Cell therapyPhase 1/2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
65/ 100

Competitive context

450 Active assets in the Melanoma cohort.

Asset / SponsorPhaseRating
Gm-Csf
Ultimovacs ASA
Phase 4BBB
Sargramostim
Mayo Clinic
Phase 3BBB
Cediranib
M.D. Anderson Cancer Center
Phase 3BBB
Ifa
Craig L Slingluff, Jr
Phase 2BB
Cyclophosphamide
Primmune Therapeutics, Inc.
Phase 4BB

View all 50 →

Same molecule, other indications

Anti-Mage-A3 Human Leukocyte Antigen Serotype Within Hla-A A Serotype Group -Restricted T-Cell Receptor is also rated in:

renal cell carcinomaDormant
CC
Indicative ·
45 / 100
View asset →
urinary bladder carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
cervical cancerDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →